Literature DB >> 2681479

Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.

P M Ueland1, H Refsum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2681479

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  71 in total

Review 1.  Blood levels of homocysteine and atherosclerotic vascular disease.

Authors:  W G Christen; P M Ridker
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Hyperhomocysteinaemia and associated disease.

Authors:  R C Bakker; D P Brandjes
Journal:  Pharm World Sci       Date:  1997-06

3.  Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine.

Authors:  Richard S Beard; Jason J Reynolds; Shawn E Bearden
Journal:  Vascul Pharmacol       Date:  2012-01-21       Impact factor: 5.773

4.  The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease.

Authors:  J B Ubbink; W J Vermaak; J M Bennett; P J Becker; D A van Staden; S Bissbort
Journal:  Klin Wochenschr       Date:  1991-08-16

5.  Total plasma homocysteine: influence of some common physiological variables.

Authors:  I Fermo; E De Vecchi; S V D'Angelo; A D'Angelo; R Paroni
Journal:  Amino Acids       Date:  1993-02       Impact factor: 3.520

6.  Homocysteine and oxidative modification of plasma proteins.

Authors:  M C Mele; E Meucci
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

7.  A community based study of the relationship between homocysteine and some of the life style factors.

Authors:  Madhumita Das; M Ghose; N C Borah; N Choudhury
Journal:  Indian J Clin Biochem       Date:  2010-08-25

8.  Homocysteine levels and risk of hip fracture in postmenopausal women.

Authors:  Meryl S Leboff; Rupali Narweker; Andrea LaCroix; Lieling Wu; Rebecca Jackson; Jennifer Lee; Douglas C Bauer; Jane Cauley; Charles Kooperberg; Cora Lewis; Asha M Thomas; Steven Cummings
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

9.  Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism.

Authors:  Anuradha Kalani; Pradip K Kamat; Anastasia Familtseva; Pankaj Chaturvedi; Nino Muradashvili; Nithya Narayanan; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-07       Impact factor: 6.200

10.  Persistent hypermethioninaemia with dominant inheritance.

Authors:  H J Blom; A J Davidson; J D Finkelstein; A S Luder; I Bernardini; J J Martin; A Tangerman; J M Trijbels; S H Mudd; S I Goodman
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.